“`html
Rise in ‘Scromiting Syndrome’ Linked to cannabis Use, Study Finds
Table of Contents
A new study reveals a critically important surge in emergency room visits related to cannabinoid hyperemesis syndrome (CHS), a condition characterized by severe, cyclical vomiting, particularly among young adults. The findings underscore that while cannabis may offer benefits, long-term use carries potential health risks that are increasingly coming to light.
Understanding Cannabinoid Hyperemesis Syndrome
cannabinoid hyperemesis syndrome (CHS) is a debilitating condition marked by intense cramps, nausea, and prolonged bouts of vomiting. sufferers often experience episodes lasting one to two days, with pain so severe it leads to involuntary screaming during vomiting – a phenomenon colloquially known as “scromiting.”
CHS typically affects individuals who have been using cannabis consistently for several years. While the exact cause remains unclear, researchers suspect it might potentially be linked to the overstimulation of cannabinoid receptors within the gastrointestinal tract. Though historically considered rare, recent data suggests a growing incidence of CHS in the United States and other regions with expanding cannabis legalization.
Did you know?-CHS episodes can last one to two days, causing severe pain and involuntary screaming during vomiting, earning it the nickname “scromiting.”
Nationwide study Reveals Alarming Trend
Researchers at the University of Illinois Chicago analyzed emergency department (ED) visits across the country between 2016 and 2022. Prior to 2020, diagnosing CHS was challenging due to a lack of standardized medical coding. To overcome this, the team identified cases involving both diagnoses of cyclical vomiting syndrome – severe, unexplained vomiting – and cannabis use as a proxy for CHS.
The analysis documented approximately 100,000 suspected cases of CHS during the study period. Rates remained stable before the COVID-19 pandemic, but surged beginning in 2020. Although cases declined somewhat in 2022, they remained elevated compared to pre-pandemic levels. Notably, the study found a concurrent rise in cannabis-related health problems generally, while instances of cyclical vomiting syndrome without any connection to cannabis did not increase, strengthening the link to CHS.
Pro tip:-Complete cessation of cannabis use is the most effective long-term solution for CHS, with symptoms typically resolving within weeks.
COVID-19 and Cannabis Legalization as Contributing Factors
The research,published Monday in JAMA Network Open,suggests the timing of the surge in CHS cases points to a potential role for the COVID-19 pandemic. “The COVID-19 pandemic likely catalyzed the rise in CHS through stress, isolation, and increased cannabis use,” the authors wrote.
However, they also emphasize that ongoing trends, such as the increasing legalization of cannabis in the U.S. and potentially higher THC concentrations in modern cannabis strains, are likely contributing factors.After peaking in 2021, CHS incidence declined but “plateaued above prepandemic levels, suggesting sustained structural or clinical drivers.”
Reader question:-Is cannabis risk-free? Researchers say no, especially with higher doses and long-term, heavy use. Increased clinical awareness is needed for accurate diagnosis.
What Can Be Done?
CHS is a distressing condition, but it is manageable and treatable. Researchers have found that hot baths and showers can provide temporary relief during acute episodes. Though, the most effective long-term solution is complete cessation of cannabis use, with symptoms typically resolving within weeks.
“Our findings shouldn’t be interpreted as a reason to panic,
